New insights in genetic cholestasis: From molecular mechanisms to clinical implications
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F18%3A00077078" target="_blank" >RIV/00023001:_____/18:00077078 - isvavai.cz</a>
Result on the web
<a href="https://www.hindawi.com/journals/cjgh/2018/2313675/" target="_blank" >https://www.hindawi.com/journals/cjgh/2018/2313675/</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1155/2018/2313675" target="_blank" >10.1155/2018/2313675</a>
Alternative languages
Result language
angličtina
Original language name
New insights in genetic cholestasis: From molecular mechanisms to clinical implications
Original language description
Cholestasis is characterised by impaired bile secretion and accumulation of bile salts in the organism. Hereditary cholestasis is a heterogeneous group of rare autosomal recessive liver disorders, which are characterised by intrahepatic cholestasis, pruritus, and jaundice and caused by defects in genes related to the secretion and transport of bile salts and lipids. Phenotypic manifestation is highly variable, ranging from progressive familial intrahepatic cholestasis (PFIC)-with onset in early infancy and progression to end-stage liver disease-to a milder intermittent mostly nonprogressive form known as benign recurrent intrahepatic cholestasis (BRIC). Cases have been reported of initially benign episodic cholestasis that subsequently transitions to a persistent progressive form of the disease. Therefore, BRIC and PFIC seem to represent two extremes of a continuous spectrum of phenotypes that comprise one disease. Thus far, five representatives of PFIC (named PFIC1-5) caused by pathogenic mutations present in both alleles of ATP8B1, ABCB11, ABCB4, TJP2, and NR1H4 have been described. In addition to familial intrahepatic cholestasis, partial defects in ATP8B1, ABCB11, and ABCB4 predispose patients to drug-induced cholestasis and intrahepatic cholestasis in pregnancy. This review summarises the current knowledge of the clinical manifestations, genetics, and molecular mechanisms of these diseases and briefly outlines the therapeutic options, both conservative and invasive, with an outlook for future personalised therapeutic strategies.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30219 - Gastroenterology and hepatology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Canadian journal of gastroenterology and hepatology
ISSN
2291-2789
e-ISSN
—
Volume of the periodical
2018
Issue of the periodical within the volume
July
Country of publishing house
EG - EGYPT
Number of pages
12
Pages from-to
"art. no. 2313675"
UT code for WoS article
000440933900001
EID of the result in the Scopus database
2-s2.0-85051257671